DAVITA INC. (NYSE:DVA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

(b)    On March 29, 2017, Roger J. Valine, a member of the Board of Directors (the “Board”) of DaVita Inc. (the “Company”) since 2006, notified the Board that he plans to retire from the Board and therefore will not stand for re-election at the Company’s 2017 Annual Meeting of Stockholders to be held in June 2017 (the “2017 Annual Meeting”). Mr. Valine has indicated his intention to continue to serve as a director of the Company until the expiration of his current term at the 2017 Annual Meeting. Mr. Valine’s decision not to stand for re-election at the Annual Meeting was not due to any disagreement with the Company.

About DAVITA INC. (NYSE:DVA)

DaVita Inc., formerly DaVita HealthCare Partners Inc., is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. The Company’s segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. The Company’s Kidney Care division is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD). HCP division is a patient and physician-focused integrated health care delivery and management company.

DAVITA INC. (NYSE:DVA) Recent Trading Information

DAVITA INC. (NYSE:DVA) closed its last trading session down -0.33 at 67.64 with 1,013,641 shares trading hands.